• 149. Back to Basics - Metastatic Hormone Sensitive Prostate Cancer

  • Mar 15 2025
  • Length: 25 mins
  • Podcast

149. Back to Basics - Metastatic Hormone Sensitive Prostate Cancer

  • Summary

  • This week, we prematurely dive into prostate cancer (one breast episode remaining - whoops!), where we explore the early pivotal trials, including the role of abiraterone in metastatic hormone-sensitive prostate cancer and the use of docetaxel in high and low-volume prostate cancer.


    Studies discussed in the episode:

    LATITUDE

    STAMPEDE


    For more episodes, resources and blog posts, visit www.inquisitiveonc.com

    Please find us on Twitter @InquisitiveOnc!

    If you want us to look at a specific trial or subject, email us at inquisitiveonc@gmail.com


    Art courtesy of Taryn Silver

    Music courtesy of AlisiaBeats: https://pixabay.com/users/alisiabeats-39461785/


    Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


    Oncology for the Inquisitive Mind is recorded with the support of education grants from our foundation partners Pfizer, Gilead Pharmaceuticals and Merck Pharmaceuticals. Our partners have access to the episode at the same time you do and have no editorial control over the content.




    Hosted on Acast. See acast.com/privacy for more information.

    Show More Show Less

What listeners say about 149. Back to Basics - Metastatic Hormone Sensitive Prostate Cancer

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.